Zanamivir not to be dispensed by nebulizer/ventilator

The anti-viral medication Zanamivir (Relenza), should be administered via a diskhaler device, is not supposed to be suspended and dispensed via nebulizer or mechanical ventilation. The FDA has released a report of a pregnant woman with influenza, who died in relation to the use of zanamivir, which was suspended and administered through a mechanical ventilator, and caused a malfunction in the ventilator equipment (FDA site). The FDA has approved the use of IV peramivir for critically ill patients with influenza.

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment